Glauber Moreira Leitao (BRA)
Degree in Medicine from the Federal University of Alagoas (1999), medical residency (lato sensu specialization) in Internal Medicine (1999-2001) and Clinical Oncology, with emphasis on the diagnosis and treatment of onco-hematological diseases and solid tumors (2001-2004 ) by the National Cancer Institute/INCA – MS. Title of Specialist in Clinical Cancerology by AMB/SBC (2004). Assistant Physician and Preceptor of Medical Residency in Clinical Oncology at Hospital das Clínicas de São Paulo/USP (2004-2006). Master’s Degree in Oncology (2008) from the University of São Paulo (USP). Assistant Physician at the Clinical Oncology Service at the Hospital do Câncer de Pernambuco from July/2008 to March/2013. Coordinator of the Committee for Ethics in Research Involving Human Beings of the Pernambuco Society of Combat/Hospital de Câncer de Pernambuco from May/2009 to March/2013. Coordinator of the Clinical Research Center of the Hospital do Câncer de Pernambuco from May/2010 to March/2013. Preceptor of Medical Residency in Clinical Oncology at Hospital das Clínicas da UFPE since 2015. Member of the Brazilian Society of Clinical Oncology (SBOC), American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO) and American Association for Cancer Research (AACR). Training in Medical Residency Preceptorship (2020) by Hospital Alemão Oswaldo Cruz/PROADI-SUS/MS. PhD in Applied Biology to Health (PhD) from the Federal University of Pernambuco (2018). Head of the Oncology and Hematology Unit at Hospital das Clinicas/EBSERH/UFPE(from July/2019 to July/2021). Graduate/Specialization in Clinical Research by UNISA-SP (2021) with Training Course in Clinical Research (2016) by Hospital Alemão Oswaldo Cruz/PROADI-SUS/MS. Graduate/Specialist in Breast Oncology at the Albert Eistein Teaching and Research Institute – Hospital Israelita Albert Einstein-SP (2021) Adjunct Professor (Superior Teaching) of Medicine (2022) at the Center for Medical Sciences/Faculty of Medicine of Recife – University Federal of Pernambuco (UFPE). Researcher at LIKA Institute (Kenzo Asami Immunopathology Laboratory) – UFPE since 2019). Head of the Care Management Division of the Health Care Management at Hospital das Clínicas-UFPE/EBSERH (since August/2021). Areas of interest: Study of Breast Neoplasms, Genitourinary Tumors, Biomarkers, Molecular Targeted Therapies, Clinical Trials, and Predictive Factors of Response to oncological therapies.
MAIN AUDITORIUM
General session 4
Coordinator:
GLAUBER MOREIRA LEITÃO (BRA)
Discussants:
RENÉ ALOISIO DA COSTA VIEIRA (BRA)
FRANKLIN FERNANDES PIMENTEL (BRA)